Skip to content
thestock.space

On 6 Nov 2026, Lenskart Solutions was priced at ₹724.75, or 160.7× trailing earnings, against an industry P/E of 28.6×. Its ROCE of 7.2% is the second-lowest among the 7 largest Medical Instruments & Supplies peers. Debt is 0.37× equity. It is a large-cap company with a market cap of ₹1.3 lakh crore, the largest of 11 Medical Instruments & Supplies companies by market cap; the shares rose 80% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹715.90
Day high
₹733.40
Day low
₹709.95
Prev. close
₹718.35
Volume
92.2 L

Health check

1 good · 1 fair · 3 to check
  • ReturnsAhead

    +79.8% over a year, better than 7 of 7 peers.

  • Price tagPricier

    P/E 160.7 vs industry 28.6.

  • Growthn/a

    Not enough yearly results to measure.

  • ProfitabilityWeak

    ROCE 7.2% vs peer median 13.3%.

  • Balance sheetFair

    Debt 0.37× equity, interest covered 4.8×, Piotroski 8 of 9.

  • Red flags1 to check

    P/E of 160.7 against an industry P/E of 28.6.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Instruments & Supplies

10 listed peers. Screen the industry

Large cap

₹1.3L Cr, the largest of 11 in its industry.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Sep 2026: sales ₹10,383 Cr · profit ₹780 Cr
Market cap
₹1.3L Cr
Large cap
P/E
160.7
Industry 28.6
Price to book
13.48
Peers 4.44
Dividend yield
0.00%
ROE
10.0%
Peers 11.0%
ROCE
7.2%
Peers 13.3%
Debt to equity
0.37
Debt ₹3,455 Cr
EPS (TTM)
₹4.51
Face value ₹2
OPM (TTM)
21.3%
Net margin 7.5%
Sales growth
+35.7%
Latest quarter vs a year ago
Profit growth
+122.1%
Latest quarter vs a year ago
Price to sales
12.09
EV/EBITDA 79.9

Strengths and risks

Strengths

  • Quarterly profit up 122.1% on a year ago.
  • Quarterly sales up 35.7% on a year ago.

Risks to check

  • P/E of 160.7 against an industry P/E of 28.6.

Derived automatically from reported figures. Not a recommendation.

About Lenskart Solutions

Lenskart Solutions Limited, a technology-driven eyewear company, engages in designing, manufacturing, branding, and retailing of eyewear products in India, Japan, Southeast Asia, the Middle East, and internationally. Its products include prescription eyeglasses, sunglasses, goggles, screen glasses, and other products, such as contact lenses and eyewear accessories, including frames for men, women, and kids. The company also engages in lens manufacturing,…

Headquarters
Gurugram
Employees
19,201
Sector
Healthcare
ISIN
INE956O01016
Website
lenskart.com

Price range

52 weeks

₹356.10₹762.75

Today

₹709.95₹733.40
Avg volume (3M)
93.2 L
1-year return
plus 79.8%
From 52-week high
minus 5.0%

Analyst consensus

25 analysts
BuyMean target ₹746.48 plus 3.0%

Target range, with today’s price

Low ₹496.00High ₹888.00

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Instruments & Supplies

Compare with peersScreen the whole industry
Company
LENSKARTLenskart Solutions724.75plus 0.89%1,25,562160.713.487.2%6.7%20.8%––0.00%plus 79.8%
AGARWALEYEDr. Agarwal's Health Care516.35plus 0.91%16,37394.17.669.7%6.8%15.0%26.9%12.3%0.00%minus 0.7%
POLYMEDPoly Medicure1,612.30plus 0.63%16,34351.45.2613.3%11.0%15.2%18.8%21.6%0.22%minus 18.1%
TARSONSTarsons Products316.95minus 0.46%1,686151.72.644.8%2.3%−0.9%14.3%−43.8%0.00%plus 10.9%
LAXMIDENTLLaxmi Dental196.42minus 0.05%1,08134.84.4411.5%12.8%16.4%19.5%–0.00%minus 37.9%
PREVESTPrevest Denpro397.85minus 3.85%47822.03.8321.9%17.8%34.8%12.4%9.3%0.25%minus 21.2%
QMSMEDIQMS Medical Allied Services168.66minus 0.69%32628.65.6818.4%10.5%12.0%18.4%16.7%0.30%plus 75.0%
SHREEPACShree Pacetronix170.00plus 0.32%6419.53.4125.0%19.7%24.8%2.2%−1.2%0.00%minus 38.5%
Median of 7 peers–−0.05%1,08134.84.4413.3%11.0%15.2%18.4%10.8%0.00%−18.1%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
2,0962,3082,5162,7142,845
1,6821,8441,9772,1262,223
414464538588622
19.8%20.1%21.4%21.7%21.9%
32.238.746.86956.3
45.248.743.553.253.2
253270288305321
–−5.3–––
148178254300304
30.1%25.6%19.9%23.8%23.7%
102131200222227
0.590.771.161.281.30

Profit & loss

Yearly, ₹ crore
ROE
10.0%
Net profitSelect a row below to chart it
₹ CrMar 2025Mar 2026
6,4938,790
5,6436,967
8491,823
13.1%20.7%
23255
146178
7971,048
24629
385680
22.8%26.4%
296494
1.722.90

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2025Mar 2026
–347
–8,391
2,5733,097
1,8002,578
10,47114,413
3,5784,705
–143
23.4198
2,0173,676
4,8525,692
10,47114,413

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2026
1,670
−2,725
1,201
145
−828
841

Shareholding pattern

Source: NSE filings
17.5%
promoters
  • Promoters17.52%
  • Public82.06%
  • Employee trusts0.42%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202617.52%82.06%minus 0.01
30 Jun 202617.53%82.05%minus 0.02
31 Mar 202617.55%82.03%minus 0.02
31 Dec 202517.57%82.01%0.00
7 Nov 202517.57%82.01%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you